✦ LIBER ✦

Gain of 1q21 Is an Unfavorable Genetic Prognostic Factor for Multiple Myeloma Patients Treated with High-Dose Chemotherapy

✍ Scribed by Pavel Nemec; Zuzana Zemanova; Henrieta Greslikova; Kyra Michalova; Hana Filkova; Jana Tajtlova; Dana Kralova; Renata Kupska; Jan Smetana; Marta Krejci; Ludek Pour; Lenka Zahradova; Viera Sandecka; Zdenek Adam; Tomas Buchler; Ivan Spicka; Evzen Gregora; Petr Kuglik; Roman Hajek

Book ID: 116281237
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 163 KB
Volume: 16
Category: Article
ISSN: 1083-8791
DOI: 10.1016/j.bbmt.2009.11.025

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Gain(1)(q21) is an Unfavorable Genetic P

Gain(1)(q21) is an Unfavorable Genetic Prognostic Factor for Patients With Relapsed Multiple Myeloma Treated With Thalidomide but Not for Those Treated With Bortezomib

✍ Smetana, Jan; Berankova, Kristina; Zaoralova, Romana; Nemec, Pavel; Greslikova, 📂 Article 📅 2013 🏛 Elsevier 🌐 English ⚖ 355 KB

1p21 deletions are strongly associated w

1p21 deletions are strongly associated with 1q21 gains and are an independent adverse prognostic factor for the outcome of high-dose chemotherapy in patients with multiple myeloma

✍ Chang, H; Qi, X; Jiang, A; Xu, W; Young, T; Reece, D 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 159 KB

1p21 deletions are strongly associated w

1p21 deletions are strongly associated with 1q21 gains and are an independent adverse prognostic factor for the outcome of high-dose chemotherapy in patients with multiple myeloma

✍ Chang, H; Qi, X; Jiang, A; Xu, W; Trieu, Y; Reece, D 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 45 KB

1q21 amplification with additional genet

1q21 amplification with additional genetic abnormalities but not isolated 1q21 gain is a negative prognostic factor in newly diagnosed patients with multiple myeloma treated with thalidomide-based regimens

✍ Grzasko, Norbert; Hus, Marek; Chocholska, Sylwia; Pluta, Andrzej; Hajek, Roman; 📂 Article 📅 2012 🏛 Informa plc 🌐 English ⚖ 265 KB

Gain of chromosome 1q21 is an independen

Gain of chromosome 1q21 is an independent adverse prognostic factor in light chain amyloidosis patients treated with melphalan/dexamethasone

✍ Bochtler, Tilmann; Hegenbart, Ute; Kunz, Christina; Benner, Axel; Seckinger, Anj 📂 Article 📅 2014 🏛 Informa plc 🌐 English ⚖ 485 KB

Abnormalities of chromosome 1p/q are hig

Abnormalities of chromosome 1p/q are highly associated with chromosome 13/13q deletions and are an adverse prognostic factor for the outcome of high-dose chemotherapy in patients with multiple myeloma

✍ Ka Lung Wu; Berna Beverloo; Henk M. Lokhorst; Christine M. Segeren; Bronno Van D 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 553 KB